Summary
The National Institutes of Health (NIH) is soliciting R33 grant applications focused on mechanistic research into precision probiotic therapies. The R33 mechanism supports the later, milestone-driven phase of high-risk, high-reward research. Clinical trials are optional under this funding opportunity. The opportunity is intended to advance scientific understanding of how probiotic interventions work at a mechanistic level, with a precision medicine orientation.
